Group 1 - The core concept of "backdoor listing" involves a non-listed company acquiring control of a listed company on the Hong Kong Stock Exchange (HKEX) to achieve indirect listing by injecting its business or assets into the listed company [3][4] - Regulatory bodies, including the Hong Kong Securities and Futures Commission and HKEX, impose strict requirements on the funding ratio, transaction structure, and source of funds to prevent circumvention of normal listing procedures [2][3] - The acquisition of control typically requires the acquirer to obtain more than 30% of the voting rights, triggering mandatory offer obligations unless an exemption is granted [5][6] Group 2 - After acquiring control, the acquirer is restricted from injecting significant new businesses or assets within 24 months, as such actions may be deemed as backdoor listings, requiring compliance with new listing application standards [4][6] - The source of funds for the acquisition must be disclosed, especially when acquiring a significant percentage of shares, and the nature of the injected assets will be scrutinized [10][11] - The relationship between the acquisition funding ratio and the nature of asset injection is critical; large-scale asset injections that significantly alter the company's original business may trigger regulatory concerns [9][10] Group 3 - Regulatory focus includes ensuring that the acquisition and subsequent asset injection have commercial rationale and are not merely for the purpose of listing [11] - The HKEX will assess whether the injected assets are primarily from the acquirer or its affiliates and whether the intent is to bypass the IPO process [10][11] - Companies considering backdoor listings are advised to consult financial and legal advisors and carefully evaluate the feasibility of this route due to increasing regulatory scrutiny [12]
【锋行链盟】港交所买壳上市收购方出资比例要求
Sou Hu Cai Jing·2025-10-14 17:21